Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  American Journal of Medicine

• Publication date

  1976-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(76)90328-4PMID 788512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gram-negative bacteremia: variable clinical course and useful prognostic factors.

  1975cited by this paper
• Radioimmunoassay, acetylating radio-enzymatic assay, and microbioassay of gentamicin: a comparative study.

  1975cited by this paper
• The unpredictability of serum concentrations of gentamicin: pharmacokinetics of gentamicin in patients with normal and abnormal renal function.

  1974cited by this paper
• Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.

  1974cited by this paper
• Reflections on the clinical pharmacology of gentamicin.

  1973cited by this paper
• Reflections on the clinical pharmacology of gentamicin.

  1973cited by this paper
• Persistent gram-negative bacteremia. Observations in twenty patients.

  1973cited by this paper
• Gram-negative bacteremia of long duration. Clinical study of 29 patients.

  1973cited by this paper
• Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.

  1971cited by this paper
• Relation between dose and levels of gentamicin in blood.

  1971cited by this paper
• Gentamicin: clinical use with carbenicillin and in-vitro studies with recent isolates of Pseudomonas aeruginosa.

  1971cited by this paper
• Antibiotic sensitivity testing. Report of an international collaborative study.

  1971cited by this paper
• Recent experience with bacillemia due to gram-negative organisms.

  1971cited by this paper
• Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.

  1971cited by this paper
• Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin.

  1971cited by this paper
• An improved single-disk method for testing the antibiotic susceptibility of rapidly-growing pathogens.

  1970cited by this paper
• INFECTIONS DUE TO GRAM-NEGATIVE ORGANISMS: AN ANALYSIS OF 860 PATIENTS WITH BACTEREMIA AT THE UNIVERSITY OF MINNESOTA MEDICAL CENTER, 1958–1966

  1969cited by this paper
• Gram-Negative Bacteremia. II. Clinical, Laboratory, and Therapeutic Observations.

  1962cited by this paper

• Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy

  2025cites this paper
• Serrating through vascular access catheters: a great masquerader with severe systemic manifestations

  2021cites this paper
• THE USE OF CLINICAL PHARMACOKINETICS IN THE DESIGN AND CONTROL OF MEDICAL PRESCRIPTION

  2016cites this paper
• Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy

  2015cites this paper
• Aminoglycoside-Induced Nephrotoxicity

  2014cites this paper
• Pharmacokinetics of Antibacterial Agents in the CSF of Children and Adolescents

  2013cites this paper
• Microbiological Investigation of Cephalosporins

  2012cites this paper
• The Pharmacological Role of the Kidney

  2012cites this paper
• Breakthrough Bacteremia and Septic Shock Due to Streptococcus anginosus Resistant to Daptomycin in a Patient Receiving Daptomycin Therapy

  2011cites this paper
• Mutations in gidB Confer Low-Level Streptomycin Resistance in Mycobacterium tuberculosis

  2011cites this paper
• Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials.

  2010cites this paper
• Therapeutic Drug Monitoring of Aminoglycosides in Neonates

  2009cites this paper
• Tratamiento antimicrobiano frente a la colonización pulmonar por Pseudomonas aeruginosa en el paciente con fibrosis quística

  2009cites this paper
• CHAPTER 98 – Disposition and Dose Requirements of Drugs in Renal Insufficiency

  2008cites this paper
• Basis for an adequate dosage of aminoglycoside antibiotics

  2005cites this paper
• The role of schedule in antibiotic therapy of the neutropenic patient

  2005cites this paper
• Indications, interpretation and applications of antibiotic assays

  2005cites this paper
• Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes

  2005cites this paper
• Review of clinical significance of synergy in gram-negative infections at the university of California Los Angeles hospital

  2005cites this paper
• Changes in gentamicin pharmacokinetic profiles induced by mechanical ventilation

  2004cites this paper
• Extended interval aminoglycoside dosing: from concept to clinic.

  2002cites this paper
• Extended-Interval Dosing of Aminoglycoside Antibiotics in Critically Ill Patients

  2002cites this paper
• Pharmacokinetics of Tobramycin in Adults with Cystic Fibrosis: Implications for Once-Daily Administration

  2000cites this paper
• Recurrent gram-negative bacteremia: incidence and clinical patterns.

  1999cites this paper
• The aminoglycosides.

  1999cites this paper
• Molecular epidemiology of gram-negative bacteremia.

  1999cites this paper
• The pharmacodynamics of aminoglycosides.

  1998cites this paper
• Therapeutic monitoring, the concentration-effect relationship and impact on the clinical efficacy of antibiotic agents.

  1997cites this paper
• A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

  1997cites this paper
• Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis.

  1997cites this paper
• Pharmacokinetics of once-daily dosing of gentamicin in neonates.

  1997cites this paper
• Pharmacodynamics and the relationship between in vitro and in vivo activity of antimicrobial agents.

  1997cites this paper
• Single or multiple daily doses of aminoglycosides: a meta- analysis

  1996cites this paper
• Standardized gentamicin dosing enhances peak serum concentrations.

  1996cites this paper
• The Effects of Age And Chemotherapy on Gentamicin Pharmacokinetics and Dosing in Pediatric Oncology Patients

  1995cites this paper
• Therapeutisches Drug Monitoring

  1995cites this paper
• Laboratory Testing of Cephalosporins

  1995cites this paper
• Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem.

  1995cites this paper
• Incidence and risk factors of recurrent episodes of bacteremia in adults.

  1994cites this paper
• Aminoglycoside dosing: time to change.

  1994cites this paper
• Problems and prospectives in the antibiotic treatment of lower respiratory tract infections.

  1994cites this paper
• Comparison of Gentamicin Pharmacokinetic Parameters Determined by Fluorescence Polarization Immunoassay and Latex Agglutination Methods

  1994cites this paper
• Clinical issues of blood cultures.

  1994cites this paper
• Aminoglycoside Dosage Regimens

  1993cites this paper
• Microdilution Antimicrobial Susceptibilities of Selected Gram-Negative Veterinary Bacterial Isolates

  1993cites this paper
• Relationship of ceftazidime pharmacokinetic indices with therapeutic outcome in patients with cystic fibrosls

  1993cites this paper
• Prediction of netilmicin disposition in neonates

  1992cites this paper
• Multidisciplinary protocol for determining aminoglycoside dosage.

  1992cites this paper
• A critical reevaluation of the "therapeutic range" of aminoglycosides.

  1992cites this paper
• Immunocompromised Host Infections

  1992cites this paper
• Considerations in Dosage Selection for Third Generation Cephalosporins

  1992cites this paper
• Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989.

  1992cites this paper
• Clinical Needs for Assays of New Antimicrobial Agents

  1991cites this paper
• The aminoglycosides.

  1991cites this paper
• Single daily dose therapy with aminoglycosides.

  1991cites this paper
• Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin

  1991cites this paper
• First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use

  1991cites this paper
• Review ofCitrobacter bacteremia in cancer patients over a sixteen-year period

  1991cites this paper
• Infections in patients in intensive care units: can the combination of a monobactam and a penicillin replace the classic combination of a beta-lactam agent and an aminoglycoside?

  1991cites this paper
• Use of aminoglycosides in critically ill patients.

  1991cites this paper
• Monitoring Serum Levels of Gentamicin to Develop a New Regimen for Gentamicin Dosage in Newborns

  1991cites this paper
• The Postantibiotic Effect: A Review of in Vitro and in Vivo Data

  1991cites this paper
• Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response

  1991cites this paper
• Effects of treatment and the metabolic response to injury on drug clearance: A prospective study with piperacillin

  1990cites this paper
• Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage

  1990cites this paper
• Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.

  1990cites this paper
• Aminoglycosides: Another Look at Current and Future Roles in Antimicrobial Therapy

  1990cites this paper
• Positive Bactec resin cultures do not influence antimicrobial selection.

  1990cites this paper
• 5 – Innovative methods of antibiotic administration

  1990cites this paper
• Thermal Injury Effects on Drug Disposition: A Prospective Study with Piperacillin

  1990cites this paper
• Pharmacokinetics of amikacin in hematologic malignancies

  1989cites this paper
• Clinical Significance of Antibiotic Tissue Penetration

  1989cites this paper
• Individualized pharmacokinetic versus standard dosing of amikacin: a comparison of therapeutic outcomes.

  1989cites this paper
• Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage.

  1989cites this paper
• Serratia bacteremia: review of 118 cases.

  1989cites this paper
• Probability Assessment Approach to Therapeutic Drug Monitoring: Tobramycin

  1989cites this paper
• Clinical implications of positive blood cultures

  1989cites this paper
• Prospective audit of aminoglycoside usage in a general hospital with assessments of clinical processes and adverse clinical outcomes

  1989cites this paper
• [Usefulness of repeated measurement of plasma levels of gentamycin].

  1989cites this paper
• Time-kill studies and synergy testing of broad-spectrum antibiotics against blood culture isolates.

  1988cites this paper
• Amikacin Pharmacokinetics in Patients with Spinal Cord Injury

  1988cites this paper
• Use of serum drug concentrations in surgical patients.

  1988cites this paper
• Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods.

  1988cites this paper
• Fever and Septicemia

  1988cites this paper
• Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers

  1988cites this paper
• Cefoperazone in the treatment of infections in cancer patients.

  1988cites this paper
• Role of pharmacokinetics in the outcome of infections

  1988cites this paper
• Aminoglycoside antibiotics in clinical use.

  1988cites this paper
• Usefulness of estimating individual pharmacokinetic data for aminoglycoside therapy in seriously ill patients.

  1987cites this paper
• The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, and sisomicin.

  1987cites this paper
• Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care.

  1987cites this paper
• CLINICAL PHARMACOKINETICS, TOXICITY AND COST EFFECTIVENESS ANALYSIS OF AMINOGLYCOSIDES AND AMINOGLYCOSIDE DOSING SERVICES

  1987cites this paper
• Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients.

  1987cites this paper
• Prognostic indicators of septicaemia--a two year prospective evaluation.

  1987cites this paper
• Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.

  1987cites this paper
• Opsonins in the hepatic clearance of pneumococci

  1987cites this paper
• Cirrhosis with ascites: A heterogeneous population

  1987cites this paper
• In vitro studies of the synergism of piperacillin and netilmicin against blood culture isolates.

  1986cites this paper
• Controversies in antimicrobial therapy: innovative methods of administration.

  1986cites this paper
• Concept of empiric therapy with antibiotic combinations. Indications and limits.

  1986cites this paper